Emmessar Biotech and Nutrition Ltd

EMMESSA Share Price

BSE

₹25.652.19% (+0.55)

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹12 cr, stock is ranked 4,775

High Risk

Stock is 5.37x as volatile as Nifty

EMMESSA Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹12 cr, stock is ranked 4,775

High Risk

Stock is 5.37x as volatile as Nifty

EMMESSA Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
38.97	1.67	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
36.92	5.82	0.58%

EMMESSA Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

EMMESSA Company Profile

Emmessar Biotech and Nutrition Ltd operates in the healthcare sector, manufacturing and trading a diverse range of products addressing various health concerns, including dermatology and muscular pains.

EMMESSA Similar Stocks (Peers)

Compare with peers Compare with peers

EMMESSA Similar Stocks (Peers)

Compare with peers Compare with peers

Sun Pharmaceutical Industries Ltd

SUNPHARMA

PE Ratio

40.09

1Y Return

10.31%

Buy Reco %

94.29

Torrent Pharmaceuticals Ltd

TORNTPHARM

PE Ratio

78.47

1Y Return

44.91%

Buy Reco %

81.48

Dr Reddy's Laboratories Ltd

DRREDDY

PE Ratio

19.51

1Y Return

18.70%

Buy Reco %

51.61

Cipla Ltd

CIPLA

PE Ratio

20.37

1Y Return

8.04%

Buy Reco %

54.84

Lupin Ltd

LUPIN

PE Ratio

32.65

1Y Return

18.65%

Buy Reco %

72.22

Compare with Peers

EMMESSA Forecast

EMMESSA Forecasts

EMMESSA

Income

Balance Sheet

Cash Flow

Financial Year		FY 2017		FY 2018		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	TTM
Total Revenue	3.59	2.52	1.93	4.87	8.46	2.28	2.77	2.55	2.62	2.54
Raw Materials	0.97	0.51	0.55	2.24	2.64	0.13	0.45	0.17	0.20	1.68
Power & Fuel Cost	0.01	0.02	0.02	0.02	0.00	0.02	0.02	0.02	0.02
Employee Cost	0.38	0.41	0.58	0.58	0.64	0.77	0.84	0.96	0.93
Selling & Administrative Expenses	0.29	0.21	0.27	0.25	0.26	0.26	0.29	0.39	0.35
Operating & Other expenses	0.73	0.52	0.14	0.97	2.60	0.08	0.11	0.10	0.07
EBITDA	1.21	0.85	0.37	0.81	2.32	1.02	1.06	0.91	1.05	0.86
Depreciation/Amortization	0.01	0.05	0.08	0.06	0.06	0.09	0.09	0.10	0.10	0.10
PBIT	1.20	0.80	0.29	0.75	2.26	0.93	0.97	0.81	0.95	0.76
Interest & Other Items	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PBT	1.19	0.80	0.29	0.75	2.26	0.93	0.97	0.81	0.95	0.76
Taxes & Other Items	0.00	-0.12	-0.24	-0.02	0.81	0.45	0.46	0.06	0.64	0.43
Net Income	1.19	0.92	0.53	0.77	1.45	0.48	0.51	0.75	0.31	0.33
EPS	2.38	1.84	1.06	1.54	2.90	0.96	1.02	1.50	0.62	0.66
DPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

EMMESSA Income Statement

Quarter		sep 2023		dec 2023		mar 2024		jun 2024		sep 2024	dec 2024	mar 2025	jun 2025	sep 2025	dec 2025
Total Revenue	0.61	0.85	0.56	0.54	0.85	0.53	0.70	0.63	0.63	0.58
Operating & Other expenses	0.30	0.53	0.47	0.35	0.42	0.38	0.42	0.37	0.46	0.43
EBITDA	0.31	0.32	0.09	0.19	0.43	0.15	0.28	0.26	0.17	0.15
Depreciation/Amortization	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.03	0.03
PBIT	0.29	0.30	0.07	0.17	0.41	0.13	0.26	0.24	0.14	0.12
Interest & Other Items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PBT	0.29	0.30	0.07	0.17	0.41	0.13	0.26	0.24	0.14	0.12
Taxes & Other Items	0.09	0.17	-0.20	0.07	0.13	0.11	0.33	0.06	0.03	0.01
Net Income	0.20	0.13	0.27	0.10	0.28	0.02	-0.07	0.18	0.11	0.11
EPS	0.39	0.26	0.71	0.18	0.56	0.03	-0.16	0.34	0.23	0.23

Financial Year		FY 2016		FY 2017		FY 2018		FY 2019		FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Cash from Operating Activities	0.44	0.75	0.74	0.39	1.03	0.47	2.27	0.38	0.64	0.22
Cash from Investing Activities	-0.46	-0.74	-0.69	-0.37	-1.06	0.01	-2.61	-0.55	-0.64	-0.23
Cash from Financing Activities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Change in Cash	-0.02	+0.01	+0.05	+0.02	-0.03	+0.48	-0.34	-0.17	+0.00	-0.01
Changes in Working Capital	+0.38	-0.50	-0.08	-0.12	+0.35	-1.72	+1.47	-0.44	+0.25	-0.37
Capital Expenditures	0.02	0.01	0.78	0.00	0.00	0.00	0.31	0.03	0.00	0.00
Free Cash Flow	0.42	0.74	-0.04	0.39	1.03	0.47	1.96	0.35	0.64	0.22

EMMESSA Company Updates

FY 2025FY 2025

Annual report

PDF

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

FY 2016FY 2016

Annual report

PDF

EMMESSA Stock Peers

EMMESSA Past Performance & Peer Comparison

Comparing 3 stocks from
Health CarePharmaceuticals

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Emmessar Biotech and Nutrition Ltd	41.48	1.67	—
Sun Pharmaceutical Industries Ltd	40.09	6.04	0.88%
Torrent Pharmaceuticals Ltd	78.47	19.76	0.72%
Dr Reddy's Laboratories Ltd	19.51	3.25	0.60%

EMMESSA Stock Price Comparison

Compare EMMESSA with any stock or ETF

EMMESSA

EMMESSA Holdings

EMMESSA Shareholdings

EMMESSA Promoter Holdings Trend

EMMESSA Institutional Holdings Trend

EMMESSA Shareholding Pattern

EMMESSA Shareholding History

Foreign Institutions

EMMESSA Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing EMMESSA stock

Looks like this stock is not in any smallcase yet.

EMMESSA Events

EMMESSA Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

EMMESSA Dividend Trend

EMMESSA Dividends

Hmm, looks like data is unavailable here. Please come back after some time

EMMESSA Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

No upcoming announcements are available

Company Update

Announced OnMar 10, 2026

Emmessar Biotech & Nutrition Ltd - 52476

Emmessar Biotech & Nutrition Ltd - 52476 Download

Link

Download

Announced On

Mar 10, 2026

Company Update

Announced OnFeb 12, 2026

Emmessar Biotech & Nutrition Ltd - 52476

Emmessar Biotech & Nutrition Ltd - 52476 Download

Link

Download

Announced On

Feb 12, 2026

Result

Announced OnFeb 11, 2026

Emmessar Biotech & Nutrition Ltd - 52476

Emmessar Biotech & Nutrition Ltd - 52476 Download

Link

Download

Announced On

Feb 11, 2026

Board Meeting

Announced OnFeb 11, 2026

Emmessar Biotech & Nutrition Ltd - 52476

Emmessar Biotech & Nutrition Ltd - 52476 Download

Link

Download

Announced On

Feb 11, 2026

Board Meeting

Announced OnFeb 4, 2026

Emmessar Biotech & Nutrition Ltd - 52476

Emmessar Biotech & Nutrition Ltd - 52476 Download

Link

Download

Announced On

Feb 4, 2026

EMMESSA Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

EMMESSA Stock News & Opinions

Earnings

Emmessar Biotech & Nutrition standalone net profit rises 500.00% in the December 2025 quarter

Net profit of Emmessar Biotech & Nutrition rose 500.00% to Rs 0.12 crore in the quarter ended December 2025 as against Rs 0.02 crore during the previous quarter ended December 2024. Sales declined 10.00% to Rs 0.09 crore in the quarter ended December 2025 as against Rs 0.10 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.090.10 -10 OPM %-366.67-280.00 - PBDT0.160.15 7 PBT0.130.13 0 NP0.120.02 500 Powered by Capital Market - Live

4 weeks agoCapital Market - Live

Corporate

Emmessar Biotech & Nutrition to conduct board meeting

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live

1 month agoCapital Market - Live

Earnings

Emmessar Biotech & Nutrition standalone net profit declines 60.71% in the September 2025 quarter

Net profit of Emmessar Biotech & Nutrition declined 60.71% to Rs 0.11 crore in the quarter ended September 2025 as against Rs 0.28 crore during the previous quarter ended September 2024. Sales declined 73.53% to Rs 0.09 crore in the quarter ended September 2025 as against Rs 0.34 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales0.090.34 -74 OPM %-411.11-23.53 - PBDT0.170.43 -60 PBT0.140.41 -66 NP0.110.28 -61 Powered by Capital Market - Live

3 months agoCapital Market - Live

Corporate

Emmessar Biotech & Nutrition to convene board meeting

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live

Corporate

Emmessar Biotech & Nutrition to convene AGM

Emmessar Biotech & Nutrition announced that the 33th Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Earnings

Emmessar Biotech & Nutrition standalone net profit rises 88.89% in the June 2025 quarter

Net profit of Emmessar Biotech & Nutrition rose 88.89% to Rs 0.17 crore in the quarter ended June 2025 as against Rs 0.09 crore during the previous quarter ended June 2024. Sales rose 12.50% to Rs 0.09 crore in the quarter ended June 2025 as against Rs 0.08 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales0.090.08 13 OPM %-311.11-350.00 - PBDT0.250.18 39 PBT0.230.16 44 NP0.170.09 89 Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Emmessar Biotech & Nutrition declare Quarterly Result

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company on 7 August 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Earnings

Emmessar Biotech & Nutrition reports standalone net loss of Rs 0.07 crore in the March 2025 quarter

Net loss of Emmessar Biotech & Nutrition reported to Rs 0.07 crore in the quarter ended March 2025 as against net profit of Rs 0.27 crore during the previous quarter ended March 2024. Sales rose 25.00% to Rs 0.10 crore in the quarter ended March 2025 as against Rs 0.08 crore during the previous quarter ended March 2024. For the full year,net profit declined 50.77% to Rs 0.32 crore in the year ended March 2025 as against Rs 0.65 crore during the previous year ended March 2024. Sales rose 8.93% to Rs 0.61 crore in the year ended March 2025 as against Rs 0.56 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales0.100.08 25 0.610.56 9 OPM %-330.00-487.50 --155.74-192.86 - PBDT0.280.09 211 1.060.91 16 PBT0.260.07 271 0.960.81 19 NP-0.070.27 PL 0.320.65 -51 Powered by Capital Market - Live

10 months agoCapital Market - Live

Corporate

Emmessar Biotech & Nutrition to hold board meeting

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company on 24 April 2025.Powered by Capital Market - Live

10 months agoCapital Market - Live

Earnings

Emmessar Biotech & Nutrition standalone net profit declines 84.62% in the December 2024 quarter

Net profit of Emmessar Biotech & Nutrition declined 84.62% to Rs 0.02 crore in the quarter ended December 2024 as against Rs 0.13 crore during the previous quarter ended December 2023. Sales declined 69.70% to Rs 0.10 crore in the quarter ended December 2024 as against Rs 0.33 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales0.100.33 -70 OPM %-280.00-63.64 - PBDT0.150.32 -53 PBT0.130.30 -57 NP0.020.13 -85 Powered by Capital Market - Live

1 year agoCapital Market - Live

Frequently asked questions

What is the share price of Emmessar Biotech and Nutrition Ltd (EMMESSA) today?
The share price of EMMESSA as on 11th March 2026 is ₹25.65. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Emmessar Biotech and Nutrition Ltd (EMMESSA) share?
The past returns of Emmessar Biotech and Nutrition Ltd (EMMESSA) share are
- Past 1 week: 5.60%
- Past 1 month: -8.33%
- Past 3 months: -14.57%
- Past 6 months: -6.02%
- Past 1 year: -23.37%
- Past 3 years: 4.00%
- Past 5 years: 56.95%
What are the peers or stocks similar to Emmessar Biotech and Nutrition Ltd (EMMESSA)?
The peers or stocks similar to Emmessar Biotech and Nutrition Ltd (EMMESSA) include:
What is the market cap of Emmessar Biotech and Nutrition Ltd (EMMESSA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Emmessar Biotech and Nutrition Ltd (EMMESSA) is ₹12.86 Cr as of 11th March 2026.
What is the 52 week high and low of Emmessar Biotech and Nutrition Ltd (EMMESSA) share?
The 52-week high of Emmessar Biotech and Nutrition Ltd (EMMESSA) is ₹42.90 and the 52-week low is ₹24.24.
What is the PE and PB ratio of Emmessar Biotech and Nutrition Ltd (EMMESSA) stock?
The P/E (price-to-earnings) ratio of Emmessar Biotech and Nutrition Ltd (EMMESSA) is 41.48. The P/B (price-to-book) ratio is 1.67.
Which sector does Emmessar Biotech and Nutrition Ltd (EMMESSA) belong to?
Emmessar Biotech and Nutrition Ltd (EMMESSA) belongs to the Health Care sector & Pharmaceuticals sub-sector.
How to buy Emmessar Biotech and Nutrition Ltd (EMMESSA) shares?
You can directly buy Emmessar Biotech and Nutrition Ltd (EMMESSA) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Emmessar Biotech and Nutrition Ltd	66.15%	47.43	Pro
Sun Pharmaceutical Industries Ltd	19.92%	72.47
Torrent Pharmaceuticals Ltd	20.80%	71.22
Dr Reddy's Laboratories Ltd	21.15%	61.97

Emmessar Biotech and Nutrition Ltd

EMMESSA Share Price

EMMESSA Stock Scorecard

EMMESSA Performance & Key Metrics

EMMESSA Performance & Key Metrics

EMMESSA Analyst Ratings & Forecast

Price Upside

Earnings Growth

Rev. Growth

EMMESSA Company Profile

EMMESSA Similar Stocks (Peers)

EMMESSA Similar Stocks (Peers)

EMMESSA Forecast

EMMESSA Forecasts

EMMESSA